O'Garra A, Murphy K
DNAX Research Institute of Molecular and Cellular Biology, Inc., Palo Alto, California 94304-1104.
Curr Opin Immunol. 1993 Dec;5(6):880-6. doi: 10.1016/0952-7915(93)90100-7.
Although differential cytokine production has been best characterized in CD4+ T cells, it is becoming clear that CD8+ T cells may also be heterogeneous at the level of cytokine production, and that this determines whether they exhibit inflammatory- or suppressor-type properties. Compelling evidence has accumulated in the past few years that cytokines such as interleukin-4, interleukin-10 and transforming growth factor-beta may serve as regulators of cell-mediated immunopathologies by inhibiting the development or effector function of inflammatory T cells that produce cytokines such as interferon-gamma or lymphotoxin.
尽管细胞因子的差异性产生在CD4+ T细胞中得到了最充分的表征,但越来越清楚的是,CD8+ T细胞在细胞因子产生水平上也可能是异质性的,并且这决定了它们是否表现出炎症型或抑制型特性。在过去几年中,已有大量令人信服的证据表明,诸如白细胞介素-4、白细胞介素-10和转化生长因子-β等细胞因子可能通过抑制产生干扰素-γ或淋巴毒素等细胞因子的炎症性T细胞的发育或效应功能,从而充当细胞介导的免疫病理的调节因子。